CISIV
Technology company developing intelligent platforms for decentralized research and late-stage clinical trials, enabling remote patient participation and streamlined trial operations.
Website
https://www.cisiv.ioLocation
United States
Founded
2020
Investors
1
Categories
clinical-trials, decentralized-trials, digital-health, research-technology
Notes
CISIV is developing intelligent technology solutions for decentralized research and late-stage clinical trials. Their platform enables sponsors and CROs to conduct hybrid and fully decentralized trials, allowing patients to participate from their homes while maintaining data quality and regulatory compliance.
The company's technology addresses the growing demand for more accessible and patient-centric clinical trial models, accelerated by the COVID-19 pandemic's impact on traditional site-based research.
Team
- Executive Team - Information not publicly available
Additional Research Findings
- Focus on decentralized clinical trials (DCT)
- Technology for remote patient participation
- Late-stage clinical trial capabilities
- Patient-centric trial design
- Regulatory compliance features
- Addressing accessibility in clinical research
Sources
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| AlbionVC (Healthcare) | London, UK | biotech-focused | seedseries-a+1 | 17 |